NEW YORK, June 6 (GenomeWeb News) - Applied Biosystems and Invitrogen will co-market and re-sell their respective protein-labeling technologies for quantitative proteomics and biomarker studies, the companies said today.
Under the agreement, the companies will jointly sell ABI's iTRAQ and ICAT protein and peptide labeling reagents, and Invitrogen's new SILAC metabolomic labeling technology. ABI will also support Invitrogen's SILAC technology with software on its TOF/TOF mass spectrometers and plans to extend software support to other mass spec types.
In addition, the companies said they will co-develop and co-market protein sample preparation kits for mass spectrometry, as well as other reagents such as matrices, solubilizers, and calibrants.
Neither company disclosed financial terms of the agreement.